Genomics of lethal prostate cancer at diagnosis and castration resistance
Joaquı́n Mateo(Hebron University), Johann S. de Bono(Royal Marsden NHS Foundation Trust), George Seed(Institute of Cancer Research), Pasquale Rescigno(Royal Marsden NHS Foundation Trust), Wei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Raquel Pérez-López(Royal Marsden NHS Foundation Trust), Bora Gürel(Institute of Cancer Research), Ursula McGovern(University College Hospital), David Dolling(Institute of Cancer Research), Matthew Clarke(Institute of Cancer Research), Rob Chandler(Royal Marsden NHS Foundation Trust), Ben Fulton(Beatson West of Scotland Cancer Centre), Robert J. Jones, Antonella Petermolo(Royal Marsden NHS Foundation Trust), Carlo Messina(Royal Marsden NHS Foundation Trust), Nina Tunariu(Leicester Royal Infirmary), Emma Hall(The Royal Wolverhampton NHS Trust), Susana Miranda(Royal Marsden NHS Foundation Trust), Shahneen Sandhu(Peter MacCallum Cancer Centre), Omi Parikh(Royal Blackburn Teaching Hospital), Mark Atkin(Institute of Cancer Research), Christy Ralph(University of Leeds), Núria Porta, Tony Elliott(The Christie Hospital), Daniel Nava Rodrigues(Royal Marsden NHS Foundation Trust), Zafeiris Zafeiriou(Royal Marsden NHS Foundation Trust), Suzanne Carreira(Institute of Cancer Research), Maialen Barrero(Royal Marsden NHS Foundation Trust), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Ines Figueiredo(Institute of Cancer Research), Mariane Fontes(Royal Marsden NHS Foundation Trust), Mohini Varughese(Musgrove Park Hospital), Cláudia Bertan(Institute of Cancer Research), Suneil Jain(Queen's University Belfast), Semini Sumanasuriya(Institute of Cancer Research)
Cited by 303
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k